Treatment of systemic mastocytosis

Author： Marrache F.   Memain N.   Bonte I.   Barete S.   Casassus P.   de Gennes C.   Fain O.   Hermine O.   Lortholary O.  

Publisher： Elsevier

ISSN： 0248-8663

Source： La Revue de Medecine Interne, Vol.24, Iss.9, 2003-09, pp. : 594-601

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic Mastocytosis

By  

Digestive Diseases, Vol. 17, Iss. 5-6, 2000-06 ,pp. : 299-307

Karger

Access to resources Recommend Favorite

Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis

By Laroche M.   Bret J.   Brouchet A.   Mazières B.  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 242-243

Springer Publishing Company

Access to resources Recommend Favorite

Systemic mastocytosis presenting as osteoporosis—a case report

By Mathew R.   Dhillon V.   Shepherd P.  

Clinical Rheumatology, Vol. 28, Iss. 7, 2009-07 ,pp. : 865-866

Springer Publishing Company

Access to resources Recommend Favorite

Indolent systemic mastocytosis associated with light chain deposition disease

By Sasaki Kotaro   Chang Alice   Najafian Behzad  

Clinical Kidney Journal, Vol. 5, Iss. 5, 2012-10 ,pp. : 424-427

Oxford University Press

Access to resources Recommend Favorite

Systemic Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 19, Iss. 4, 2002-03 ,pp. : 311-323

Karger

Access to resources Recommend Favorite